Cogent Biosciences (COGT)
(Delayed Data from NSDQ)
$10.74 USD
+0.46 (4.47%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $10.75 +0.01 (0.09%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -0.55 |
EPS Last Quarter | -0.59 |
Last EPS Surprise | -7.27% |
ABR | 1.45 |
Earnings ESP
|
-0.67% |
---|---|
Current Year | -2.26 |
Next Year | -2.19 |
EPS (TTM) | -2.48 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 10.60M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 10.60M |
Low Estimate | NA | NA | NA | 10.60M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.55 | -0.56 | -2.26 | -2.19 |
# of Estimates | 7 | 7 | 7 | 6 |
Most Recent Consensus | -0.61 | -0.62 | -2.26 | -2.21 |
High Estimate | -0.44 | -0.43 | -1.99 | -1.59 |
Low Estimate | -0.67 | -0.69 | -2.56 | -2.82 |
Year ago EPS | -0.64 | -0.63 | -2.42 | -2.26 |
Year over Year Growth Est. | 14.06% | 11.11% | 6.61% | 3.21% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 1 | 2 | 1 |
Up Last 60 Days | 2 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 3 | 4 | 3 | 3 |
Down Last 60 Days | 3 | 4 | 3 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.55 | -0.56 | -2.26 | -2.19 |
7 Days Ago | -0.55 | -0.56 | -2.26 | -2.19 |
30 Days Ago | -0.54 | -0.54 | -2.19 | -2.04 |
60 Days Ago | -0.54 | -0.54 | -2.19 | -2.04 |
90 Days Ago | -0.54 | -0.54 | -2.19 | -2.04 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.56 | -0.56 | -2.27 | -2.10 |
Zacks Consensus Estimate | -0.55 | -0.56 | -2.26 | -2.19 |
Earnings ESP | -0.67% | 0.76% | -0.43% | 4.30% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.59 | -0.62 | -0.63 | -0.64 | NA |
Estimate | -0.55 | -0.50 | -0.54 | -0.50 | NA |
Difference | -0.04 | -0.12 | -0.09 | -0.14 | -0.10 |
Surprise | -7.27% | -24.00% | -16.67% | -28.00% | -18.99% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more